CompletedNCT00283517
A Registry of Treatment Adherence for Patients With Schizophrenia
Observational studyAges 18+
Understand this study
Who was this study for?
Listed age limits: from 18 years.
Study information
Study start dateSeptember 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 2,046
- Sponsor
- Janssen-Cilag, S.A.
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- Over 18 Years
- Official registry ID
- NCT00283517
- Official title
Show the full official title
Electronic Schizophrenia Treatment Adherence Registry, eSTAR
Recruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is Janssen-Cilag, S.A.
Did this study involve medication?
Yes. The study involved medication, including antipsychotics.
Who was this study for?
Listed age limits: from 18 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)
A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)